![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
As of October 2023, Amedeo had |
Multiple Sclerosis |
Free Subscription
1 Acta Neuropathol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Multiple Sclerosis is free of charge.
Microglia activation in periplaque white matter in multiple sclerosis depends on
age and lesion type, but does not correlate with oligodendroglial loss.
Acta Neuropathol. 2023 Oct 28. doi: 10.1007/s00401-023-02645.
PubMed
Abstract available
Multimodal agility-based exercise training (MAT) versus strength and endurance
training (SET) to improve multiple sclerosis-related fatigue and fatigability
during inpatient rehabilitation: a randomized controlled pilot and feasibility
study [ReFEx].
BMC Neurol. 2023;23:388.
PubMed
Abstract available
Comorbid autoimmune disorders in people with multiple sclerosis: A retrospective
cohort study.
J Neuroimmunol. 2023;385:578226.
PubMed
Abstract available
Halting progressive multifocal leukoencephalopathy with pembrolizumab: the case
of a patient with multiple sclerosis under fingolimod.
J Neurol. 2023 Nov 1. doi: 10.1007/s00415-023-12055.
PubMed
Serum sickness in a multiple sclerosis patient treated with ocrelizumab.
J Neurol. 2023 Oct 31. doi: 10.1007/s00415-023-12082.
PubMed
Ocrelizumab exposure in relapsing-remitting multiple sclerosis: 10-year analysis
of the phase 2 randomized clinical trial and its extension.
J Neurol. 2023 Oct 31. doi: 10.1007/s00415-023-11943.
PubMed
Abstract available
Key characteristics of anti-CD20 monoclonal antibodies and clinical implications
for multiple sclerosis treatment.
J Neurol. 2023 Oct 31. doi: 10.1007/s00415-023-12007.
PubMed
Abstract available
Exploring the cost-effectiveness of EBV vaccination to prevent multiple sclerosis
in an Australian setting.
J Neurol Neurosurg Psychiatry. 2023 Nov 2:jnnp-2023-332161.
PubMed
Abstract available
Radiologically isolated syndrome.
Lancet Neurol. 2023 Oct 4:S1474-4422(23)00281.
PubMed
Abstract available
The CogEx trial - Cognitive rehabilitation and aerobic exercise for cognitive
impairment in people with progressive multiple sclerosis: A randomised, blinded,
sham-controlled trial.
Mult Scler. 2023 Nov 2:13524585231210178. doi: 10.1177/13524585231210178.
PubMed
Re-thinking race and geography in multiple sclerosis.
Mult Scler. 2023 Oct 31:13524585231205969. doi: 10.1177/13524585231205969.
PubMed
Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: Final
safety and efficacy results from the phase 3 EVOLVE-MS-1 study.
Mult Scler. 2023 Oct 31:13524585231205708. doi: 10.1177/13524585231205708.
PubMed
Abstract available
Mobile health interventions in multiple sclerosis: A systematic review.
Mult Scler. 2023 Oct 28:13524585231201089. doi: 10.1177/13524585231201089.
PubMed
Abstract available
A closer look at reported colitis in association with multiple sclerosis
treatments.
Mult Scler. 2023 Oct 28:13524585231205964. doi: 10.1177/13524585231205964.
PubMed
Thank you for your interest in scientific medicine.